指南与共识糖尿病性腺与生殖内分泌

支持既存糖尿病与妊娠管理临床实践指南的系统综述

A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy.
指南 / 共识 · J Clin Endocrinol Metab · 2025-01-01

本系统综述汇总了17项研究,为内分泌学会既存糖尿病妊娠管理指南提供证据支持。Meta分析显示混合闭环胰岛素泵与标准治疗在范围内时间无显著差异,但夜间范围内时间更优;二甲双胍联合胰岛素与较低大于胎龄儿风险相关。

要点

  • 混合闭环胰岛素泵与标准治疗在总体范围内时间无显著差异,但夜间范围内时间更优。
  • 二甲双胍联合胰岛素与较低的大于胎龄儿风险相关(2项随机对照试验,1126例患者)。
  • 3项回顾性研究提示39周前诱导分娩与新生儿并发症增加相关,但可能存在混杂。

核心结论

  • 本系统综述涉及既存糖尿病妊娠管理的多个方面,将支持内分泌学会指南的制定。

研究设计与样本

  • 系统综述,检索MEDLINE、EMBASE、Scopus等来源至2025年2月,共纳入17项研究,由独立评审员配对筛选和提取数据。

主要发现

  • Meta分析显示混合闭环胰岛素泵与标准治疗在范围内时间、高于范围内时间和低于范围内时间方面无显著差异,混合闭环胰岛素泵的夜间范围内时间和夜间低于范围内时间更优。
  • 对于2型糖尿病女性,间歇使用持续血糖监测与大于胎龄儿风险无显著变化相关(2项随机对照试验,102例患者)。
  • 二甲双胍联合胰岛素与较低的大于胎龄儿风险相关(2项随机对照试验,1126例患者)。
  • 3项回顾性研究(1724例患者)提示既存1型和2型糖尿病女性在39周前(尤其是38周前)诱导分娩时新生儿并发症增加,但该证据可能存在混杂。
  • 一项回顾性研究显示围受孕期暴露于胰高血糖素样肽-1受体激动剂未增加新生儿并发症。

关键数值与推荐

  • 未能识别评估关于妊娠可能性筛查问题或限制碳水化合物饮食的比较研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 关于39周前诱导分娩与新生儿并发症增加相关的证据可能存在混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Women with preexisting diabetes mellitus (PDM) are at increased risk of pregnancy-related complications. OBJECTIVE: To summarize the available supporting evidence for the Endocrine Society guidelines about management of PDM in pregnancy. DATA SOURCES: MEDLINE, EMBASE, Scopus, and other sources through February 2025. STUDY SELECTION: Studies were selected by pairs of independent reviewers. DATA EXTRACTION: Data were extracted by pairs of independent reviewers. DATA SYNTHESIS: We included 17 studies. Meta-analysis showed no significant difference between hybrid closed-loop insulin pump (HCL) and standard of care regarding time in range (TIR), time above range (TAR), and time below range (TBR). HCL had better overnight TIR and TBR. For women with type 2 diabetes mellitus (T2DM), intermittent use of continuous glucose monitoring (CGM) was not associated with a significant change in the risk of large for gestational age (LGA) neonates (2 randomized controlled trials [RCTs], 102 patients). Adding metformin to insulin was associated with a lower risk of LGA (2 RCTs, 1126 patients). Three retrospective studies (1724 patients) suggested increased neonatal complications when delivery was induced before 39 weeks of gestation (particularly before 38 weeks) in women with preexisting type 1 (T1DM) and T2DM, although this evidence was subject to likely confounding. One retrospective study showed no increase in neonatal complications with periconceptional exposure to glucagon-like peptide-1 receptor agonists. We could not identify comparative studies assessing a screening question about the possibility of pregnancy or a carbohydrate restrictive diet. CONCLUSION: This systematic review addresses various aspects of managing PDM in pregnancy and will support the development of the Endocrine Society guidelines.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Al Nofal A, Benkhadra K, Abbas A, et al. A Systematic Review Supporting the Clinical Practice Guidelines on the Management of Preexisting Diabetes and Pregnancy. J Clin Endocrinol Metab. 2025. PMID: 40652449. doi:10.1210/clinem/dgaf289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。